levofloxacin has been researched along with 2019 Novel Coronavirus Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dogan, A; Donmez, F | 1 |
| Djilas, M; Marković, M; Milosavljević, B; Petrović, V; Ristić, M | 1 |
| Boyanova, L; Gergova, G; Gergova, R; Kandilarov, N; Markovska, R; Yordanov, D | 1 |
| Ellakany, WI; Ghazy, RM; Ismail, A; Kamal, A; Sherief, D | 1 |
| Bulychev, VV; Bulycheva, EV; Pashkova, NA | 1 |
| Azadi, H; Darabi, E; Fathi, S; Ghanei, M; Ghazale, AH; Ghazvini, A; Izadi, M; Jafari, R; Movaseghi, F; Mozafari, A; Panahi, Y; Parsaei, MR; Ranjkesh, MH; Rezapour, M; Saadat, SH; Salesi, M; Vahedi, E; Zand, N | 1 |
| Allen, MB; Neal, JM; Vlassakov, K | 1 |
| Akbulut Koyuncu, İM; Kızıltunç, E; Uğurlu Ilgın, B | 1 |
1 trial(s) available for levofloxacin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; COVID-19; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Pandemics; Proton Pump Inhibitors; Treatment Outcome | 2023 |
7 other study(ies) available for levofloxacin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Investigation of the effects of three different generations of fluoroquinolone derivatives on antioxidant and immunotoxic enzyme levels in different rat tissues.
Topics: Adenosine Deaminase; Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Ciprofloxacin; COVID-19; Creatinine; Fluoroquinolones; Glucose; Glutathione; Glutathione Peroxidase; Levofloxacin; Lipid Peroxidation; Malondialdehyde; Moxifloxacin; Nalidixic Acid; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; SARS-CoV-2; Superoxide Dismutase; Triglycerides | 2022 |
Pneumococcal carriage in adults aged 50 years and older in outpatient health care facility during pandemic COVID-19 in Novi Sad, Serbia.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Carrier State; Ceftriaxone; Child; COVID-19; Delivery of Health Care; Erythromycin; Female; Humans; Infant; Levofloxacin; Middle Aged; Nasopharynx; Outpatients; Pandemics; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Serbia; Serogroup; Streptococcus pneumoniae; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Geographic distribution of antibiotic resistance of Helicobacter pylori: A study in Bulgaria.
Topics: Amoxicillin; Anti-Bacterial Agents; Bulgaria; Clarithromycin; COVID-19; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Pandemics | 2023 |
[The problem of formation of new risks of medicinal resistance of patients with tuberculosis in condition of active use of antibiotics by population under COVID-19].
Topics: Anti-Infective Agents; Antitubercular Agents; Azithromycin; COVID-19; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; Mycobacterium tuberculosis; Pandemics; Quinolones; Tuberculosis | 2023 |
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Levofloxacin; Lopinavir; Male; Meropenem; Middle Aged; Naproxen; Oseltamivir; Pneumonia, Viral; Prednisolone; Retrospective Studies; Ritonavir; Treatment Outcome; Vancomycin | 2020 |
Neuraxial anaesthesia in the context of bacterial meningitis and COVID-19.
Topics: Anesthesia, Spinal; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Coronavirus Infections; COVID-19; Humans; Levofloxacin; Male; Meningitis, Bacterial; Middle Aged; Pandemics; Pneumonia, Viral; Risk Factors | 2020 |
Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydroxychloroquine; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Oseltamivir; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Young Adult | 2021 |